Zac Germon retweetledi
proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases academic.oup.com/neuro-oncology…
English
Zac Germon
64 posts
Zac Germon
@ZacGermon
Post Doctoral Scientist @ University of Newcastle | Cell Signalling | Proteomics | Leukaemia + DIPG | CSRG #DunLab
Katılım Eylül 2019
158 Takip Edilen110 Takipçiler
@MattDun17 @charles_debock @NatureComms @KidsCancerInst I have! Amazing data, congrats to all involved.
English
@charles_debock @NatureComms @KidsCancerInst Fantastic Dominik, Charley, Richard and Duohui.
@ZacGermon have you seen this?
English
Following our publication on T-ALL this week, pleased to share another paper from our group now published in @NatureComms linking PU.1 to glucocorticoid sensitivity in B-ALL rdcu.be/dZB01 which was a massive team effort @KidsCancerInst ; 🧵n/8 below
English
Had a great day at @TheASMR1 Hunter meeting. Grateful to have been awarded Best ECR/MCR talk on the day!
English
So proud of #DunLab PhD warrior @Mika_Persson97 receiving the best abstract award at the #ANZCHOG2024asm!! @RUNDIPG
Matt Dun, PhD@MattDun17
Super #ANZCHOG2024asm so far. Privileged to see the pioneering work of Prof Eric Bouffet @SickKidsNews & A/Prof @VitanzaNick (support by @RUNDIPG) & delighted that our talented #DunLab PhD students @Bryce_Thomas23 & @Mika_Persson97 were selected to present their #DIPG #DMG data.
English
Thanks Heather, looking forward to it!
Heather Lee@Dr_Heather_Lee
On July 18, I'll be hosting @XuDongZhang15 and @ZacGermon at an online seminar for @AEpiA. I'm looking forward to showcasing the work of two great colleagues from @UON_research and @HMRIAustralia . Tune in for some fabulous science and discussion!
English
Thanks @CancerAustralia & @KidsCancerProj! Excited to be given the opportunity to continue this project investigating much needed novel treatment strategies for Paediatric cancers #AML #DMG #DIPG
Matt Dun, PhD@MattDun17
Delighted #DunLab 's childhood cancer project was funded by @CancerAustralia & @KidsCancerProj Free-radicals (#ROS) promote cancer signaling in RTK mutant- #AML & #DMG #DIPG Here we will develop new targeted treatments Congrats @ZacGermon @duchatel_ryan @Jonatha16752881 DE & ID
English
Zac Germon retweetledi
Wonderful to see the glossy version & cover of #DunLab’s latest paper discovering the genetic dependency & targeting of PI3K in #DIPG #DMG
Huge thanks to the funders & parents who donated their child’s tissues to help us in this & all our important studies doi.org/10.1172/JCI170…
Journal of Clinical Investigation@jclinicalinvest
#Cover: Targeting PI3K/mTOR in diffuse intrinsic pontine glioma: buff.ly/3TAz4Jd #Image presents a model whereby the connectivity of these cancers can be harnessed using integrated technologies to identify potential therapeutic strategies. #Oncology #Therapeutics
English
Happy to announce that 2024 marks a new chapter for me as I'm joining the Menzies Institute for Medical Research in the beautiful city of Hobart, a place very close to my heart. I'm very excited for this opportunity and look forward to further developing my research program here.
English
Congratulations @MattDun17! So well deserved. Your dedication and determination inspire us each day in the fight against kids cancer!
Matt Dun, PhD@MattDun17
So thankful to receive this prestigious award on behalf of our incredible #DunLab team May I thank all our #CSRG team & recognise the inspirational scientists that did all the work particularly @evierjackson @duchatel_ryan @AliciaD0uglas @DilanaStaudt @ZacGermon #DIPG 💪 @RUNDIPG
English
Zac Germon retweetledi
Congrats, Sam and team! A super interesting review. Thank you for the opportunity to contribute.
Heather Lee@Dr_Heather_Lee
Our new review on #hypoxia and #DNAmethylation in #AML is online today. We explored complex and bi-directional interactions between hypoxia signalling and regulation of DNA methylation as well as implications for AML therapy. …lepigeneticsjournal.biomedcentral.com/articles/10.11…
English
English
@Bryce_Thomas23 @DilanaStaudt @MattDun17 @VitanzaNick @michelle_monje Congrats Bryce and team, on a great paper and an awesome image!
English
@MattDun17 @PrecisionMedUON @UON_research Thanks Matt, and thank you for all the support and opportunities you have given me along the way. To be continued!
English
What’s better than watching & being part of your PhD students- Dr @ZacGermon, now superstar postdoc’s, graduation..
Not much!
Congratulations mate, thanks for choosing me as your supervisor & for your handwork, dedication & friendship #DunLab #CSRG @PrecisionMedUON @UON_research
English
Congrats Evie and team! Great summary of this paper below.
Evie Jackson@evierjackson
Incredibly proud to share the latest work from #DunLab, published in #CancerResearch! We highlight the combination of ONC201 and paxalisib for the treatment of DMG, the preclinical data informing PNOC022. Follow this tweetorial for a summary: (1/10) aacrjournals.org/cancerres/arti…
English
Zac Germon retweetledi
A new study shows that inhibiting the oxidase NOX2 suppresses a common subtype of #AcuteMyeloidLeukemia (AML) in mice by blocking ROS in cancer cells—hinting that targeting NOX2 may potentiate precision therapies for AML. @ZacGermon @MattDun17 scim.ag/26a
English
Zac Germon retweetledi
Probably my favourite part of adding to the literature, students/stuff pinning their first author papers to our walls of honour!
#DunLab #CSRG
Matt Dun, PhD@MattDun17
#DunLab paper alert: Patients diagnosed with the most common driver mutation in acute myeloid leukemia (AML) – FLT3, are associated with poor-outcomes. FLT3+ AML sees the overproduction of reactive oxygen species (ROS), a second messenger signaling (T1) doi.org/10.1126/scisig…
English
Excited to see this paper published today in @scisignal. This work formed a large part of my PhD and is summarised below:
Matt Dun, PhD@MattDun17
#DunLab paper alert: Patients diagnosed with the most common driver mutation in acute myeloid leukemia (AML) – FLT3, are associated with poor-outcomes. FLT3+ AML sees the overproduction of reactive oxygen species (ROS), a second messenger signaling (T1) doi.org/10.1126/scisig…
English